位置:首页 > 蛋白库 > PIPNA_RAT
PIPNA_RAT
ID   PIPNA_RAT               Reviewed;         271 AA.
AC   P16446;
DT   01-AUG-1990, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   03-AUG-2022, entry version 156.
DE   RecName: Full=Phosphatidylinositol transfer protein alpha isoform;
DE            Short=PI-TP-alpha;
DE            Short=PtdIns transfer protein alpha;
DE            Short=PtdInsTP alpha;
GN   Name=Pitpna; Synonyms=Pitpn;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=2777797; DOI=10.1016/s0021-9258(19)84743-9;
RA   Dickeson S.K., Lim C.N., Schuyler G.T., Dalton T.P., Helmkamp G.M. Jr.,
RA   Yarbrough L.R.;
RT   "Isolation and sequence of cDNA clones encoding rat phosphatidylinositol
RT   transfer protein.";
RL   J. Biol. Chem. 264:16557-16564(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Heart;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   PROTEIN SEQUENCE OF 2-21.
RC   TISSUE=Lung;
RX   PubMed=3606604; DOI=10.1016/0006-291x(87)91580-4;
RA   Funkhouser J.D.;
RT   "Amino-terminal sequence of a phospholipid transfer protein from rat
RT   lung.";
RL   Biochem. Biophys. Res. Commun. 145:1310-1314(1987).
RN   [4]
RP   PROTEIN SEQUENCE OF 9-31; 88-96; 136-147 AND 235-244, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY.
RC   STRAIN=Sprague-Dawley; TISSUE=Spinal cord;
RA   Lubec G., Afjehi-Sadat L., Shim K.;
RL   Submitted (DEC-2006) to UniProtKB.
RN   [5]
RP   FUNCTION, CATALYTIC ACTIVITY, AND MUTAGENESIS OF SER-25; THR-59; HIS-60;
RP   PRO-78; THR-198 AND GLU-248.
RX   PubMed=7568025; DOI=10.1073/pnas.92.19.8826;
RA   Alb J.G. Jr., Gedvilaite A., Cartee R.T., Skinner H.B., Bankaitis V.A.;
RT   "Mutant rat phosphatidylinositol/phosphatidylcholine transfer proteins
RT   specifically defective in phosphatidylinositol transfer: implications for
RT   the regulation of phospholipid transfer activity.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:8826-8830(1995).
RN   [6]
RP   FUNCTION, CATALYTIC ACTIVITY, AND ACTIVITY REGULATION.
RX   PubMed=18636990; DOI=10.1111/j.1600-0854.2008.00794.x;
RA   Shadan S., Holic R., Carvou N., Ee P., Li M., Murray-Rust J., Cockcroft S.;
RT   "Dynamics of lipid transfer by phosphatidylinositol transfer proteins in
RT   cells.";
RL   Traffic 9:1743-1756(2008).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS).
RX   PubMed=11104777; DOI=10.1074/jbc.m010131200;
RA   Yoder M.D., Thomas L.M., Tremblay J.M., Oliver R.L., Yarbrough L.R.,
RA   Helmkamp G.M. Jr.;
RT   "Structure of a multifunctional protein. Mammalian phosphatidylinositol
RT   transfer protein complexed with phosphatidylcholine.";
RL   J. Biol. Chem. 276:9246-9252(2001).
CC   -!- FUNCTION: Catalyzes the transfer of phosphatidylinositol (PI) and
CC       phosphatidylcholine (PC) between membranes (PubMed:7568025,
CC       PubMed:18636990). Shows a preference for PI and PC containing shorter
CC       saturated or monosaturated acyl chains at the sn-1 and sn-2 positions
CC       (By similarity). Preference order for PC is C16:1 > C16:0 > C18:1 >
CC       C18:0 > C20:4 and for PI is C16:1 > C16:0 > C18:1 > C18:0 > C20:4 >
CC       C20:3 (By similarity). {ECO:0000250|UniProtKB:Q00169,
CC       ECO:0000269|PubMed:18636990, ECO:0000269|PubMed:7568025}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1,2-diacyl-sn-glycero-3-phosphocholine(in) = a 1,2-diacyl-
CC         sn-glycero-3-phosphocholine(out); Xref=Rhea:RHEA:38571,
CC         ChEBI:CHEBI:57643; Evidence={ECO:0000269|PubMed:7568025};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38572;
CC         Evidence={ECO:0000305|PubMed:7568025};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol)(in) = a
CC         1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol)(out);
CC         Xref=Rhea:RHEA:38691, ChEBI:CHEBI:57880;
CC         Evidence={ECO:0000269|PubMed:18636990, ECO:0000269|PubMed:7568025};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:38692;
CC         Evidence={ECO:0000305|PubMed:7568025};
CC   -!- ACTIVITY REGULATION: Phosphatidylinositol transfer activity is
CC       inhibited by N-ethylmaleimide. {ECO:0000269|PubMed:18636990}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P53810}. Nucleus
CC       {ECO:0000250|UniProtKB:P53810}.
CC   -!- TISSUE SPECIFICITY: Expressed in a wide range of tissues.
CC       {ECO:0000269|PubMed:2777797}.
CC   -!- PTM: Phosphorylated by PKC in a calcium and phosphatidylserine-
CC       dependent manner. {ECO:0000250|UniProtKB:P53810}.
CC   -!- SIMILARITY: Belongs to the PtdIns transfer protein family. PI transfer
CC       class I subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M25758; AAA41984.1; -; mRNA.
DR   EMBL; BC070945; AAH70945.1; -; mRNA.
DR   PIR; A34391; A34391.
DR   RefSeq; NP_058927.1; NM_017231.1.
DR   PDB; 1T27; X-ray; 2.20 A; A=1-271.
DR   PDBsum; 1T27; -.
DR   AlphaFoldDB; P16446; -.
DR   SMR; P16446; -.
DR   BioGRID; 248161; 1.
DR   STRING; 10116.ENSRNOP00000005368; -.
DR   iPTMnet; P16446; -.
DR   PhosphoSitePlus; P16446; -.
DR   SwissPalm; P16446; -.
DR   World-2DPAGE; 0004:P16446; -.
DR   jPOST; P16446; -.
DR   PaxDb; P16446; -.
DR   PRIDE; P16446; -.
DR   Ensembl; ENSRNOT00000005368; ENSRNOP00000005368; ENSRNOG00000003846.
DR   GeneID; 29525; -.
DR   KEGG; rno:29525; -.
DR   CTD; 5306; -.
DR   RGD; 61885; Pitpna.
DR   eggNOG; KOG3668; Eukaryota.
DR   HOGENOM; CLU_046509_0_0_1; -.
DR   InParanoid; P16446; -.
DR   OrthoDB; 951268at2759; -.
DR   PhylomeDB; P16446; -.
DR   TreeFam; TF313279; -.
DR   EvolutionaryTrace; P16446; -.
DR   PRO; PR:P16446; -.
DR   Proteomes; UP000002494; Chromosome 10.
DR   Bgee; ENSRNOG00000003846; Expressed in cerebellum and 20 other tissues.
DR   ExpressionAtlas; P16446; baseline and differential.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0000062; F:fatty-acyl-CoA binding; IDA:UniProtKB.
DR   GO; GO:0031210; F:phosphatidylcholine binding; IDA:BHF-UCL.
DR   GO; GO:0120019; F:phosphatidylcholine transfer activity; IMP:UniProtKB.
DR   GO; GO:0008525; F:phosphatidylcholine transporter activity; IDA:BHF-UCL.
DR   GO; GO:0035091; F:phosphatidylinositol binding; IDA:UniProtKB.
DR   GO; GO:0008526; F:phosphatidylinositol transfer activity; IDA:UniProtKB.
DR   GO; GO:0005543; F:phospholipid binding; IDA:MGI.
DR   GO; GO:0070540; F:stearic acid binding; IDA:UniProtKB.
DR   GO; GO:0007409; P:axonogenesis; ISO:RGD.
DR   GO; GO:0015914; P:phospholipid transport; IDA:UniProtKB.
DR   Gene3D; 3.30.530.20; -; 1.
DR   InterPro; IPR001666; PI_transfer.
DR   InterPro; IPR023393; START-like_dom_sf.
DR   PANTHER; PTHR10658; PTHR10658; 1.
DR   Pfam; PF02121; IP_trans; 1.
DR   PRINTS; PR00391; PITRANSFER.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Cytoplasm; Direct protein sequencing;
KW   Lipid transport; Lipid-binding; Nucleus; Reference proteome; Transport.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:3606604"
FT   CHAIN           2..271
FT                   /note="Phosphatidylinositol transfer protein alpha isoform"
FT                   /id="PRO_0000191642"
FT   REGION          251..271
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         59
FT                   /ligand="a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-
FT                   inositol)"
FT                   /ligand_id="ChEBI:CHEBI:57880"
FT                   /evidence="ECO:0000305|PubMed:7568025"
FT   BINDING         61
FT                   /ligand="a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-
FT                   inositol)"
FT                   /ligand_id="ChEBI:CHEBI:57880"
FT                   /evidence="ECO:0000250|UniProtKB:Q00169"
FT   BINDING         86
FT                   /ligand="a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-
FT                   inositol)"
FT                   /ligand_id="ChEBI:CHEBI:57880"
FT                   /evidence="ECO:0000250|UniProtKB:Q00169"
FT   BINDING         90
FT                   /ligand="a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-
FT                   inositol)"
FT                   /ligand_id="ChEBI:CHEBI:57880"
FT                   /evidence="ECO:0000250|UniProtKB:Q00169"
FT   BINDING         97
FT                   /ligand="a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-
FT                   inositol)"
FT                   /ligand_id="ChEBI:CHEBI:57880"
FT                   /evidence="ECO:0000250|UniProtKB:Q00169"
FT   BINDING         195
FT                   /ligand="a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-
FT                   inositol)"
FT                   /ligand_id="ChEBI:CHEBI:57880"
FT                   /evidence="ECO:0000250|UniProtKB:Q00169"
FT   MOD_RES         216
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q00169"
FT   MUTAGEN         25
FT                   /note="S->F: Loss of phosphatidylinositol transfer activity
FT                   but no significant effect on phosphatidylcholine transfer
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:7568025"
FT   MUTAGEN         59
FT                   /note="T->A: Reduced phosphatidylinositol and
FT                   phosphatidylcholine transfer activity."
FT                   /evidence="ECO:0000269|PubMed:7568025"
FT   MUTAGEN         59
FT                   /note="T->S,Q,V,I,N,D,E: Loss of phosphatidylinositol
FT                   transfer activity but no significant effect on
FT                   phosphatidylcholine transfer activity."
FT                   /evidence="ECO:0000269|PubMed:7568025"
FT   MUTAGEN         60
FT                   /note="H->Q: No significant effect on phosphatidylinositol
FT                   and phosphatidylcholine transfer activity."
FT                   /evidence="ECO:0000269|PubMed:7568025"
FT   MUTAGEN         78
FT                   /note="P->L: Loss of phosphatidylinositol transfer activity
FT                   but no significant effect on phosphatidylcholine transfer
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:7568025"
FT   MUTAGEN         198
FT                   /note="T->I: No significant effect on phosphatidylinositol
FT                   and phosphatidylcholine transfer activity."
FT                   /evidence="ECO:0000269|PubMed:7568025"
FT   MUTAGEN         248
FT                   /note="E->K: Loss of phosphatidylinositol transfer activity
FT                   but no significant effect on phosphatidylcholine transfer
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:7568025"
FT   CONFLICT        14
FT                   /note="S -> H (in Ref. 3; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   STRAND          3..13
FT                   /evidence="ECO:0007829|PDB:1T27"
FT   HELIX           15..32
FT                   /evidence="ECO:0007829|PDB:1T27"
FT   STRAND          38..49
FT                   /evidence="ECO:0007829|PDB:1T27"
FT   STRAND          55..64
FT                   /evidence="ECO:0007829|PDB:1T27"
FT   TURN            66..68
FT                   /evidence="ECO:0007829|PDB:1T27"
FT   HELIX           71..74
FT                   /evidence="ECO:0007829|PDB:1T27"
FT   TURN            79..82
FT                   /evidence="ECO:0007829|PDB:1T27"
FT   STRAND          84..91
FT                   /evidence="ECO:0007829|PDB:1T27"
FT   STRAND          94..100
FT                   /evidence="ECO:0007829|PDB:1T27"
FT   TURN            102..104
FT                   /evidence="ECO:0007829|PDB:1T27"
FT   HELIX           105..107
FT                   /evidence="ECO:0007829|PDB:1T27"
FT   STRAND          108..119
FT                   /evidence="ECO:0007829|PDB:1T27"
FT   TURN            124..127
FT                   /evidence="ECO:0007829|PDB:1T27"
FT   HELIX           133..136
FT                   /evidence="ECO:0007829|PDB:1T27"
FT   STRAND          138..142
FT                   /evidence="ECO:0007829|PDB:1T27"
FT   HELIX           147..149
FT                   /evidence="ECO:0007829|PDB:1T27"
FT   TURN            152..154
FT                   /evidence="ECO:0007829|PDB:1T27"
FT   HELIX           157..159
FT                   /evidence="ECO:0007829|PDB:1T27"
FT   TURN            161..163
FT                   /evidence="ECO:0007829|PDB:1T27"
FT   TURN            167..169
FT                   /evidence="ECO:0007829|PDB:1T27"
FT   HELIX           178..182
FT                   /evidence="ECO:0007829|PDB:1T27"
FT   STRAND          186..188
FT                   /evidence="ECO:0007829|PDB:1T27"
FT   STRAND          191..201
FT                   /evidence="ECO:0007829|PDB:1T27"
FT   TURN            204..206
FT                   /evidence="ECO:0007829|PDB:1T27"
FT   HELIX           207..231
FT                   /evidence="ECO:0007829|PDB:1T27"
FT   HELIX           233..236
FT                   /evidence="ECO:0007829|PDB:1T27"
FT   HELIX           241..260
FT                   /evidence="ECO:0007829|PDB:1T27"
SQ   SEQUENCE   271 AA;  31907 MW;  F06794CD1930EDA9 CRC64;
     MVLLKEYRVI LPVSVDEYQV GQLYSVAEAS KNETGGGEGV EVLVNEPYEK DDGEKGQYTH
     KIYHLQSKVP TFVRMLAPEG ALNIHEKAWN AYPYCRTVIT NEYMKEDFLI KIETWHKPDL
     GTQENVHKLE PEAWKHVEAI YIDIADRSQV LSKDYKAEED PAKFKSIKTG RGPLGPNWKQ
     ELVNQKDCPY MCAYKLVTVK FKWWGLQNKV ENFIHKQEKR LFTNFHRQLF CWLDKWVDLT
     MDDIRRMEEE TKRQLDEMRQ KDPVKGMTAD D
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024